Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia

VANCOUVER, Dec. 12, 2017 -- (Healthcare Sales & Marketing Network) - Cardiome Pharma Corp. (NASDAQ: CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced that it... Biopharmaceuticals, Cardiology, Licensing Cardiome Pharma, ZAO Firma Euroservice, Correvio, Aggrastat
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news